At the molecular level, immunohistochemical analysis revealed elevated <i>CD34</i> and <i>PPARG</i> expression and reduced <i>PTEN</i> expression in AML compared with normal tissues (p<0.05). This evidence concerns the gene CD34 and acute myeloid leukemia.